Serum Cytokine of IL-10 and IL-12 in Chronic Liver Disease: The Immune and Inflammatory Response

Disease Markers
Hoda Mohamed El-EmshatyIbrahim Eldsoky Mohamed

Abstract

The current study was designed to investigate the potential association of serum interleukin-10 and interleukin-12 with HCV infection in chronic liver disease and to evaluate their possible role as new biomarkers in HCC development. Material and Methods. Forty-one patients suffering from chronic liver disease (33 patients harbor HCV infection and 8 are HCV-negative patients) were enrolled in the present study and histopathologically diagnosed into 15 patients with HCC, 16 patients with LC, and 10 patients with liver histology compatible with precirrhotic hepatitis (PCH). Ten patients complaining of cholecystitis were included as nondisease control. Serum levels of IL-10 and IL-12 were measured by enzyme linked immunosorbent assay (ELISA). Results. HCV-infected patients showed elevated expression of IL-10 and IL-12 compared to nondisease controls (P < 0.0001) but there is no significant difference with respect to their expression in HCV-negative patients. Serum IL-10 and IL-12 were elevated significantly with disease progression (P < 0.0001) and a positive correlation coefficient was detected between IL-10, IL-12 (r = 0.785, P < 0.0001), and transaminase values suggesting their possible role in chronic inflammation progression l...Continue Reading

References

Feb 1, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S L TsaiG C Kuo
Feb 12, 1998·The Journal of Experimental Medicine·G Schuler, R M Steinman
Sep 2, 2003·Cytokine & Growth Factor Reviews·Wendy T WatfordJohn J O'Shea
Nov 4, 2004·International Journal of Cancer. Journal International Du Cancer·Yoshihiko TokusashiKatsuhiro Ogawa
Nov 1, 2005·Cancer Control : Journal of the Moffitt Cancer Center·Motawa E el-HouseiniAnwar A Elsayed
Jan 21, 2006·World Journal of Gastroenterology : WJG·Abdel-Rahman N ZekriMaha A Abu-Shady
Dec 5, 2006·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·C-Y HsiaS-D Lee
Aug 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michele Del VecchioAndrea Anichini
Sep 11, 2007·World Journal of Gastroenterology : WJG·Eva BillerbeckRobert Thimme
Sep 15, 2007·World Journal of Gastroenterology : WJG·Guido RasiClaudio Puoti
Feb 12, 2008·Trends in Molecular Medicine·Willscott E Naugler, Michael Karin
Sep 3, 2008·Journal of Gastroenterology and Hepatology·Kazumasa HiroishiMichio Imawari
Jan 3, 2009·Biochemical and Biophysical Research Communications·Lei WanFuu-Jen Tsai
Apr 4, 2009·American Journal of Physiology. Gastrointestinal and Liver Physiology·Roben G GielingYuan-Ping Han
May 19, 2010·European Cytokine Network·Francesca CaponeGiuseppe Castello
Nov 18, 2010·European Cytokine Network·Susan CostantiniGiuseppe Castello
Nov 19, 2013·Journal of Infection in Developing Countries·Moataza H OmranMostafa K El Awady

❮ Previous
Next ❯

Citations

Jan 30, 2019·Journal of Gastroenterology and Hepatology·Elizabeth C TownsendTheo Heller
Aug 23, 2019·Archives of Toxicology·Vanessa HartwigSteven Dooley
Jan 24, 2021·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hugo BarraguéEric Champagne
Apr 16, 2021·The Cochrane Database of Systematic Reviews·Agostino ColliGiovanni Casazza

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
ELISA
enzyme linked immunosorbent assay

Related Concepts

Related Feeds

Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.